Boston Angel Investors →
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
CEO and Fund Manager, Renaissance Venture Capital Fund
CEO of Dynamis Corporation
Founder and Managing Director of DEV
Partner at New Enterprise Associates
VP of Research and Special Initiatives, Google
May 11, 2017 ·
May 31, 2017 ·
June 8, 2017 ·
Actinium is developing cancer drugs that are antibodies linked to radioisotopes.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.